Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Safety and Efficacy Study of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment

ClinicalTrials.gov ID: NCT03567057

Public ClinicalTrials.gov record NCT03567057. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 6:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Open-Label Safety and Efficacy Study of ADS-5102 Amantadine Extended Release Capsules in Patients With Multiple Sclerosis and Walking Impairment

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study assessed the long-term safety and tolerability of ADS-5102 in subjects with MS and walking impairment who had completed the double-blind, placebo-controlled study of ADS-5102 in subjects with MS (ADS-AMT-301).

Study identification

NCT ID
NCT03567057
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Adamas Pharmaceuticals, Inc.
Industry
Enrollment
424 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 18, 2018 (Actual)
Primary completion
Nov 17, 2020 (Actual)
Completion
Apr 18, 2021 (Actual)
Last update posted
Jan 18, 2022

2018 – 2021

United States locations

U.S. sites
82
U.S. states
32
U.S. cities
78
Facility City State ZIP Site status
Adamas Clinical Site Cullman Alabama 35058 —
Adamas Clinical Site Phoenix Arizona 85018 —
Adamas Clinical Site Phoenix Arizona 85032 —
Adamas Clinical Site Tucson Arizona 85704 —
Adamas Clinical Site Carlsbad California 92011 —
Adamas Clinical Site Fresno California 93710 —
Adamas Clinical Site Fullerton California 92835 —
Adamas Clinical Site Long Beach California 90806 —
Adamas Clinical Site Newport Beach California 92663 —
Adamas Clinical Site Sacramento California 95817 —
Adamas Clinical Site Aurora Colorado 80045 —
Adamas Clinical Site Colorado Springs Colorado 80907 —
Adamas Clinical Site Denver Colorado 800209 —
Adamas Clinical Site Fort Collins Colorado 80528 —
Adamas Clinical Site Fairfield Connecticut 06824 —
Adamas Clinical Site New London Connecticut 06320 —
Adamas Clinical Site Washington D.C. District of Columbia 20007 —
Adamas Clinical Site Maitland Florida 32751 —
Adamas Clinical Site Miami Florida 33136 —
Adamas Clinical Site Miami Florida 33176 —
Adamas Clinical Site Naples Florida 34105 —
Adamas Clinical Site Orlando Florida 32806 —
Adamas Clinical Site Ormond Beach Florida 32174 —
Adamas Clinical Site Palm Coast Florida 32164 —
Adamas Clinical Site Port Charlotte Florida 33952 —
Adamas Clinical Site Sarasota Florida 34233 —
Adamas Clinical Site St. Petersburg Florida 33713 —
Adamas Clinical Site Tampa Florida 33609 —
Adamas Clinical Site Vero Beach Florida 32960 —
Adamas Clinical Site Atlanta Georgia 30309 —
Adamas Clinical Site Savannah Georgia 31406 —
Adamas Clinical Site Northbrook Illinois 60062 —
Adamas Clinical Site Indianapolis Indiana 46256 —
Adamas Clinical Site Kansas City Kansas 66103 —
Adamas Clinical Site Lenexa Kansas 66214 —
Adamas Clinical Site Overland Park Kansas 66212 —
Adamas Clinical Site Burlington Massachusetts 01805 —
Adamas Clinical Site Foxborough Massachusetts 02035 —
Adamas Clinical Site Worcester Massachusetts 01655 —
Adamas Clinical Site Detroit Michigan 42801 —
Adamas Clinical Site Farmington Hills Michigan 48334 —
Adamas Clinical Site Golden Valley Minnesota 55422 —
Adamas Clinical Site Kansas City Missouri 64111 —
Adamas Clinical Site St Louis Missouri 63110 —
Adamas Clinical Site Great Falls Montana 59405 —
Adamas Clinical Site Lincoln Nebraska 68506 —
Adamas Clinical Site Omaha Nebraska 68105 —
Adamas Clinical Site Las Vegas Nevada 89106 —
Adamas Clinical Site Albuquerque New Mexico 87106 —
Adamas Clinical Site Amherst New York 14226 —
Adamas Clinical Site Lake Success New York 11042 —
Adamas Clinical Site New York New York 10029 —
Adamas Clinical Site Patchogue New York 11772 —
Adamas Clinical Site Plainview New York 11803 —
Adamas Clinical Site Rochester New York 14642 —
Adamas Clinical Site Staten Island New York 10306 —
Adamas Clinical Site Charlotte North Carolina 28204 —
Adamas Clinical Site Raleigh North Carolina 27607 —
Adamas Clinical Site Centerville Ohio 45459 —
Adamas Clinical Site Cleveland Ohio 44195 —
Adamas Clinical Site Columbus Ohio 43214 —
Adamas Clinical Site Oklahoma City Oklahoma 73104 —
Adamas Clinical Site Portland Oregon 97213 —
Adamas Clinical Site Philadelphia Pennsylvania 19140 —
Adamas Clinical Site Charleston South Carolina 29406 —
Adamas Clinical Site Greer South Carolina 29650 —
Adamas Clinical Site Rock Hill South Carolina 29732 —
Adamas Clinical Site Spartanburg South Carolina 29307 —
Adamas Clinical Site Cordova Tennessee 38018 —
Adamas Clinical Site Franklin Tennessee 37064 —
Adamas Clinical Site Johnson City Tennessee 37604 —
Adamas Clinical Site Houston Texas 77030 —
Adamas Clinical Site Houston Texas 77074 —
Adamas Clinical Site Lubbock Texas 79410 —
Adamas Clinical Site Round Rock Texas 78681 —
Adamas Clinical Site Salt Lake City Utah 84103 —
Adamas Clinical Site Newport News Virginia 23601 —
Adamas Clinical Site Norfolk Virginia 23502 —
Adamas Clinical Site Kirkland Washington 98034 —
Adamas Clinical Site Seattle Washington 98122 —
Adamas Clinical Site Seattle Washington 98191 —
Adamas Clinical Site Milwaukee Wisconsin 53215 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03567057, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 18, 2022 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03567057 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →